ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NGM NGM Biopharmaceuticals Inc

1.54
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
NGM Biopharmaceuticals Inc NASDAQ:NGM NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.54 1.54 1.35 0 01:00:00

NGM Bio to Participate in Upcoming Investor Conferences

07/11/2023 9:05pm

GlobeNewswire Inc.


NGM Biopharmaceuticals (NASDAQ:NGM)
Historical Stock Chart


From Jun 2023 to Jun 2024

Click Here for more NGM Biopharmaceuticals Charts.

NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that David J. Woodhouse, Ph.D., Chief Executive Officer, will participate in a fireside chat at the upcoming 6th Annual Evercore ISI HealthCONx Conference and will present an overview of the company and provide a business update. Management will also be available for investor meetings at the upcoming Jefferies London Healthcare Conference.

Jefferies London Healthcare Conference 2023November 14 – 16, 2023

6th Annual Evercore ISI HealthCONx ConferenceWednesday, November 29, 2023, 8:45 am ET

About NGM BioNGM Bio is focused on discovering and developing novel, life-changing medicines for people whose health and lives have been disrupted by disease. The company’s biology-centric drug discovery approach aims to seamlessly integrate interrogation of complex disease-associated biology and protein engineering expertise to unlock proprietary insights that are leveraged to generate promising product candidates and enable their rapid advancement into proof-of-concept studies. As explorers on the frontier of life-changing science, NGM Bio aspires to operate one of the most productive research and development engines in the biopharmaceutical industry. All therapeutic candidates in the NGM Bio pipeline have been generated by its in-house discovery engine, always led by biology and motivated by unmet patient need. Visit us at www.ngmbio.com for more information.

Investor Contact:ir@ngmbio.com

Media Contact:media@ngmbio.com

 

 

 

1 Year NGM Biopharmaceuticals Chart

1 Year NGM Biopharmaceuticals Chart

1 Month NGM Biopharmaceuticals Chart

1 Month NGM Biopharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock